This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma | MicrobiomeTrials
← Back to trials NCT04609046
Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2021-05-24Est. Completion: 2027-04-01
Enrollment target: 47 participantsLocations Cedars-Sinai Medical Center, Los Angeles, California, United States UCSF Medical Center-Parnassus, San Francisco, California, United States UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida, United States University of Miami Sylvester Comprehensive Cancer Center at Sole Mia, North Miami, Florida, United States UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States Saint Anthony Regional Hospital, Carroll, Iowa, United States UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States Iowa Methodist Medical Center, Des Moines, Iowa, United States UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States Other microbiome trials you might be interested in Primary Central Nervous System Lymphoma
BACKGROUND:
* Primary CNS lymphoma (PCNSL) is a rare subtype of diffuse large B-cell lymphoma.
* The outcome for patien…
Bethesda, United States Est. completion Sep 1, 2026
Refractory Diffuse Large B Cell Lymphoma (DLBCL) Relapsed Diffuse Large B Cell Lymphoma High Grade B-cell Lymphoma (HGBCL) Primary Mediastinal B-cell Lymphoma (PMBCL) Transformed Lymphoma Central Nervous System Lymphoma
Broadlawns Medical Center, Des Moines, Iowa, United States
Mercy Medical Center - Des Moines, Des Moines, Iowa, United States
UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States
Iowa Lutheran Hospital, Des Moines, Iowa, United States
UI Healthcare Mission Cancer and Blood - Fort Dodge, Fort Dodge, Iowa, United States
University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States
UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States
Methodist West Hospital, West Des Moines, Iowa, United States
LSU Health Baton Rouge-North Clinic, Baton Rouge, Louisiana, United States
Our Lady of the Lake Physician Group, Baton Rouge, Louisiana, United States
MaineHealth Maine Medical Center - Portland, Portland, Maine, United States
MaineHealth Maine Medical Center- Scarborough, Scarborough, Maine, United States
MaineHealth Cancer Care and IV Therapy - South Portland, South Portland, Maine, United States
Hickman Cancer Center, Adrian, Michigan, United States
Toledo Clinic Cancer Centers-Monroe, Monroe, Michigan, United States
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States
Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States
Washington University School of Medicine, St Louis, Missouri, United States
Siteman Cancer Center-South County, St Louis, Missouri, United States
Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States
Overlook Hospital, Summit, New Jersey, United States
Northwell Health/Center for Advanced Medicine, Lake Success, New York, United States
North Shore University Hospital, Manhasset, New York, United States
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States
NYP/Weill Cornell Medical Center, New York, New York, United States
State University of New York Upstate Medical University, Syracuse, New York, United States
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, United States
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Rhode Island Hospital, Providence, Rhode Island, United States
Medical University of South Carolina, Charleston, South Carolina, United States
UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
West Virginia University Healthcare, Morgantown, West Virginia, United States
Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States
Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States
Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States
Marshfield Medical Center - Minocqua, Minocqua, Wisconsin, United States
Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, United States
Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, United States
Marshfield Medical Center - Weston, Weston, Wisconsin, United States Mantle Cell Lymphoma (MCL)
Richter Transformation
Transplant-ineligible 2nd Line DLBCL
DALY II USA is a phase II, multi-center, single arm study to evaluate the efficacy, safety, and pharmacokinetics of zamt…
Birmingham, United States Est. completion Dec 31, 2026